Groundbreaking science is just the beginning. What truly determines a longevity company’s success is how vision translates into strategy — and how both align with culture, compliance, and execution. In this panel, seasoned founders, HR experts, and industry partners discuss what

We’re just 10 days away from our Los Angeles Longevity Investors Summit! We have an incredible lineup of speakers—many of whom you’ve never seen in the same room before! Whether you’re a grassroots member, a startup founder, an investor, or part of an industry preparing for

In case you missed it, a hot-mic moment at Beijing’s WWII anniversary parade this week captured Xi and Putin discussing immortality and the future of human longevity. But the real story is about how China and Russia are making longevity and biotechnology national priorities.

🚀 Calling all longevity biotech startups! We’re thrilled to announce the Longevity Investors Summit in Los Angeles, an official LA Tech Week event. With an impressive lineup of standout companies from the Bay Area and LA already confirmed, this gathering will bring together

✉ Let’s keep the momentum going. Help us reach 400 letters (and beyond)! Since July, our community has sent 375 letters to Congress urging support for longevity science. We’re so close to 400 and with Members of Congress in their final week of summer recess, this is the perfect

📷 @davidasinclair & I would like to share with you at #SWSX the science, ethics, and economics of #longevity science and cellular #rejuvenation. But we need your help: vote *this week* for our session https://t.co/d1nA4JYHtH

#SXSW2026 voting is open! COO, @M_S_Ringel, JD, PhD, & co-founder & board chair, @DavidASinclair, AO, PhD, will explore how aging can be targeted at a molecular level to extend healthspan & the related economic, ethical, & global implications. Vote here: https://t.co/2cYwN7vpOk

This week on A4LI’s Scientist Spotlight, we chat with Jillian Cox, PhD Candidate in Dr. Sarah Ocañas' (@OcanasSR) Lab at Oklahoma Medical Research Foundation (@OMRF). Growing up in Oklahoma, Jillian’s curiosity led her down the path of science. In our conversation, she shares

Want to help push aging biology research forward? 🚀 You can make an impact today: 📝 Speak up — Contact your local representatives and state senators. Email us at info@a4li.org for tips on what to say. 💬 Share your story — Tell us why this research matters to you:

We're hosting a Longevity SF Hike at the end of the month! Come join us! Register here: https://t.co/iXHkh1kjua.

The totally groundless firing of Dr. Erika McEntarfer, my successor as Commissioner of Labor Statistics at BLS, sets a dangerous precedent and undermines the statistical mission of the Bureau. For a full statement opposing this move, read:

We recently partnered with @OctaneOC to boost visibility for longevity science in the medical industry, as they explore The Science of Longevity at their Medical Innovation Forum this October. Join top leaders in medtech, healthcare, and investment for two days of cutting-edge

🚨 𝗧𝗵𝗲 𝗧𝗿𝗮𝗻𝘀-𝗡𝗜𝗛 𝗚𝗲𝗿𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗜𝗻𝘁𝗲𝗿𝗲𝘀𝘁 𝗚𝗿𝗼𝘂𝗽 (𝗚𝗦𝗜𝗚) 𝗶𝘀 𝗯𝗮𝗰𝗸! Launched in 2012 by Dr. Felipe Sierra, then Director of the NIA Division of Aging Biology, the GSIG was established on the recognition that aging biology is a fundamental

This week we talk with @M_S_Ringel about how @lifebiosciences is developing therapies based on partial epigenetic reprogramming: a way to reverse cellular aging while preserving cell identity. 🎧 Apple: https://t.co/e9IYbdpbb4 Spotify: https://t.co/q0AffjWl5e

🚨 As agencies discuss the implementation of New Approach Methodologies (NAMs), it’s critical we don’t leave behind what still works. 🧬 Mice are still the gold standard for aging research, offering whole-organism insights, rapid testing, and decades of proven value. 📉

This week on A4LI’s Scientist Spotlight, we chat with Seth Ashby,  a research associate in Dr. Angeli's lab at the University of Maine. In this episode, we discuss how Seth's experience working at a short-staffed nursing home during the pandemic led to him becoming interested in

Program Manager Dr. Jean Hebert talks about our new FRONT program which asks, what if we could restore function to the millions of Americans with permanent brain damage to the neocortex? Learn more about FRONT: https://t.co/5HO3tOJVo9

Millions of Americans are living with the damage caused by strokes and traumatic brain injuries. Today we launched a program in ARPA-H to restore function to the neocortex.

NEW: No technology currently exists to repair damaged brain tissue and fully restore lost function. FRONT aims to enable millions with what is considered permanent brain damage to regain lost functions, including motor control, vision, and speech.

We're just as excited about the new ARPA-H program, FRONT, as you are! It's truly transformative for patients currently suffering from permanent neurological damage with no immediate cure.